Electronic Drug Product Reporting for Human Drug Compounding Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act”
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
January 3, 2017
April 28, 2022
663cef2e-7472-423d-8bba-249d7de0ea3d
Related Documents
Prescription Requirement Under Section 503A of the Federal Food, Drug, and Cosmetic Act Guidance for Industry
Guidance DocumentDecember 29, 2016Center for Drug Evaluation and Research
Adverse Event Reporting for Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act
Guidance DocumentOctober 8, 2015Center for Drug Evaluation and Research
Guidance For Entities Considering Whether to Register As Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act
Guidance DocumentAugust 11, 2015Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.